Longevity Patent Family

Methods and Formulations for Immuno-Rejuvenation to Prevent or Mitigate Inflammaging Through the Epigenetic Impact of a Polyphenol-Rich Agent Derived from Uniquely Applied Tartary Buckwheat

Source-linked patent metadata for Methods and Formulations for Immuno-Rejuvenation to Prevent or Mitigate Inflammaging Through the Epigenetic Impact of a Polyphenol-Rich Agent Derived from Uniquely Applied Tartary Buckwheat, including priority, record stage and longevity-topic connections.

Patent-family snapshot

Application publication visible

Family grouping brings related publications for the same invention together, instead of counting every national filing as a separate technology.

Representative publication
US20260158096A1
Earliest priority
December 6, 2024
Latest publication
June 11, 2026
Family publications
1
Patent offices
1
Patent-to-Evidence Translation Map

What is happening in the same scientific field?

These connections share a longevity topic with this patent record. They do not prove that the listed evidence, trials, funders, or universities validate, finance, own, or support this invention.

Organizations

Organizations named in this family

Big Bold HealthApplicantBIG BOLD HEALTH [US]Applicant
Longevity context

Topics connected by metadata

Chronic inflammation88% metadata match
Polyphenols and ageing88% metadata match
Knowledge connections

What this family cites

Earlier patent references
0
Scientific and other non-patent references
0
Priority dates represented
2

References show which earlier documents the patent record points to. They do not validate the invention or prove that cited research supports its claims.

Technical classification

How the patent office classifies this invention

No patent classification is available in the retained record.

Verify in the original patent source →